Medical Condition

malignant solid neoplasm

Total Trials

14

Recruiting Now

14

Trial Phases

Phase 1, Phase 3

ClinicalMetric tracks all active clinical trials for malignant solid neoplasm sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — malignant solid neoplasm Clinical Trials

How many clinical trials are currently recruiting for malignant solid neoplasm?

ClinicalMetric currently tracks 14 actively recruiting clinical trials for malignant solid neoplasm, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for malignant solid neoplasm?

malignant solid neoplasm research spans Phase 1 (2 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a malignant solid neoplasm clinical trial?

Eligibility criteria for malignant solid neoplasm trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 3

Top Sponsors

Mayo Clinic 5 trials

M.D. Anderson Cancer Center 2 trials

Wake Forest University Health Sciences 2 trials

Roswell Park Cancer Institute 1 trial

University of Michigan Rogel Cancer Center 1 trial

Recruiting Clinical Trials

NCT00991094

Recruiting

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

M.D. Anderson Cancer Center

View Trial →

NCT06897137

Recruiting

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Wake Forest University Health ...

View Trial →

NCT07805083

Recruiting

Community Enhanced Virtual Informed Consent

Community-Based Physical Activity Intervention for Underserved Cancer Survivors

Roswell Park Cancer Institute

View Trial →

NCT07365007

Recruiting

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel C...

View Trial →

NCT06709404

Recruiting

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

Wake Forest University Health ...

View Trial →

NCT07325006

Recruiting

Impact of Physician Behavior on Cancer Distress

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

M.D. Anderson Cancer Center

View Trial →

NCT05006482 Phase 3

Recruiting

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

University of Rochester

View Trial →

NCT07291011

Recruiting

A Mindfulness-Based Stress Reduction Program for Improving Mental Health Outcomes for Underserved Cancer Patients in Minnesota

Wearable Activity Tracking to Curb Hospitalizations

University of California, San ...

View Trial →

NCT07221409

Recruiting

Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

Wisconsin Ginseng for Decreasing Cancer Related Fatigue

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Enrollment

300 pts

Location

United States, Canad...

Sponsor

National Cancer Institute (NCI...

View Trial →

Related Conditions

hematopoietic and lymphatic system neoplasm (6) hematopoietic and lymphoid cell neoplasm (2) lymphatic system neoplasm (2) hematopoietic and lymphoid system neoplasm (2) breast carcinoma (1) esophageal carcinoma (1) genitourinary system carcinoma (1) head and neck carcinoma (1) lung carcinoma (1) malignant central nervous system neoplasm (1) malignant digestive system neoplasm (1) hematopoietic neoplasms (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology